HealthQuill Articles by: HealthQuill
More than 3,700 babies in the US were born with syphilis in 2022 — ten times the number in 2012 — and people from racial and ethnic minorities bore the brunt of the epidemic eight times more than White mothers.
Health Research

Infant mortality increase in US states with abortion bans: An analysis

Infant Mortality Increase in States with Abortion Bans: An In-Depth Analysis HQ Team February 15, 2025:Two recent studies published in the Journal of the

Read More
Sound therapy through singing bowl, it heals and brings peace
Opinion

Power of sound therapy: Enhancing wellness through vibrational healing

Alvina Miller February 14, 2025: Do you ever think about how sound can help heal the mind and body? Music listening therapy, one

Read More
The first dosing in a late-stage trial to evaluate an investigational drug for tuberculosis (TB) has started in South Africa, which has one of the highest burdens in the world.
Health Research

Urgent global action needed as multidrug-resistant TB surges among children

HQ Team February 14, 2025: Multidrug-resistant tuberculosis (MDR-TB) among children worldwide is a “silent epidemic” that needs immediate intervention. New data reveals that

Read More
Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for adult and pediatric heart patients, according to a statement.
Uncategorized

US scientists make heart valves to aid tissue regeneration, avoid surgeries

Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for

Read More
Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion to expand its cardiovascular pipeline.
Uncategorized

Switzerland’s Novartis to buy US-based Anthos for $3.1 billion

Novartis AG, one of the world’s top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion

Read More
The US’s medical research agency has discovered more than 3,000 new types of brain cells in different clusters of the organ that may help in the treatment of cancer and neurodegenerative diseases.
Opinion

Decoding the murderous mind: The neuroscience behind killers

By Aparna S February 11, 2025: Criminal psychology delves into the shadows of human behavior to unravel why individuals commit heinous crimes like

Read More
Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of Mumbai and Ahmedabad in association with Mayo Clinic Global Consulting, according to a statement.
Uncategorized

Indian billionaire Adani to invest $686.2m to build 2 health campuses

Billionaire Gautam Adani’s family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of

Read More
Forty-nine bodies, likely of migrants, were found in two mass graves in Libya, according to the UN agency, the International Office of Migration.
Climate Health Medical

UN says 49 bodies of possible migrants found in two Libyan mass graves

Forty-nine bodies, likely of migrants, were found in two mass graves in Libya, according to the UN agency, the International Office of Migration.

Read More
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to the Massachusetts-based firm.
Drugs Health Medical

Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion

Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to

Read More
The US Food and Drug Administration has approved Ionis Pharmaceuticals’ drug to treat a rare and life-threatening genetic disease known as familial chylomicronemia syndrome (FCS), according to a statement.
Drugs Pharma

AbbVie’s drug-resistant abdominal infection medicine gets US nod

HQ Team February 10, 2025: The U.S. Food and Drug Administration (FDA) has approved Emblaveo, a new antibiotic combination of aztreonam and avibactam,

Read More